Feature

Protection can be a necessity for some clients, yet they find themselves declined by mainstream insurers. Roger Hillier explains impaired health policies

It is during hard times that people need protection the most but persuading them to part with their cash may be difficult. Roger Edwards offers some marketing advice

A European cross-border health directive may seem good news for UK patients. But do overseas care packages inadvertently overlook 'hidden' expenses? Jack Briggs argues treatment in the UK through a PMI policy would be better value

With little product innovation at the moment, protection providers are being forced to compete with price. Lucy Quinton explains why the changing rates of last year look set to continue

Haemochromatosis is when the body absorbs excess iron which is then deposited in its organs causing enlargement and irreparable damage. Peter Jolliffe explains the effects of the disease and how it can be treated

Can a provider's claims statistics be taken at face value? Dale Tranter dissects the data to examine what contributes to the figures made available to the public

Bernie Hickman makes the case for the industry to push customer engagement, regulation and the issues - defining the way forward before it is too late

Protection has always been expensive for those in high risk occupations, but is it fair that consumers may compromise on product quality? Paul Wood examines the case for IP

Many advisers view lead generation firms with suspicion, but is this justified? Justin Rees explains how purchasing consumer information in the form of leads can help new business blossom

Being off work for extended periods impacts on a person's wellbeing as well as their income. Chris McFarlane notes advisers could make more of rehabilitation services as a sales tool